1. Author Response: Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study. (10th January 2023) Authors: van Kleef, Laurens A.; Xiao, Tian; de Knegt, Robert J.; Ikram, M. Arfan Journal: Neurology Issue: Volume 100:Number 2(2023) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Can we predict the future of patients with liver cirrhosis using volumetrics?. Issue 8 (12th September 2022) Authors: Lantinga, Marten A.; van Kleef, Laurens A. Journal: United European Gastroenterology journal Issue: Volume 10:Issue 8(2022) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study. Issue 2 (15th February 2023) Authors: van Kleef, Laurens A.; Sonneveld, Milan J.; Kavousi, Maryam; Ikram, M. Arfan; de Man, Robert A.; de Knegt, Robert J. Journal: Hepatology Issue: Volume 77:Issue 2(2023) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality. Issue 3 (17th March 2023) Authors: van Kleef, Laurens A.; de Knegt, Robert J.; Brouwer, Willem Pieter Journal: Hepatology Issue: Volume 77:Issue 3(2023) Page Start: 942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. Issue 2 (13th December 2021) Authors: van Kleef, Laurens A.; Ayada, Ibrahim; Alferink, Louise J.M.; Pan, Qiuwei; de Knegt, Robert J. Journal: Hepatology Issue: Volume 75:Issue 2(2022) Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modifiable risk factors for fatty liver disease: Time to act. Issue 3 (17th March 2023) Authors: van Kleef, Laurens A.; de Knegt, Robert J. Journal: Hepatology Issue: Volume 77:Issue 3(2023) Page Start: 712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study. (16th February 2022) Authors: van Kleef, Laurens A.; Hofman, Amy; Voortman, Trudy; de Knegt, Robert J. Journal: American journal of gastroenterology Issue: Volume 117:Number 2(2022) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reply to: "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD". Issue 9 (20th May 2022) Authors: van Kleef, Laurens A.; de Knegt, Robert J. Journal: Hepatology communications Issue: Volume 6:Issue 9(2022) Page Start: 2605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reply. Issue 2 (3rd February 2023) Authors: van Kleef, Laurens A.; Sonneveld, Milan J.; de Knegt, Robert J. Journal: Hepatology Issue: Volume 77:Issue 2(2023) Page Start: E30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Reply. Issue 3 (17th March 2023) Authors: van Kleef, Laurens A.; de Knegt, Robert J.; Brouwer, Willem Pieter Journal: Hepatology Issue: Volume 77:Issue 3(2023) Page Start: E45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗